SCHEMBL6808725

SCHEMBL6808725

CC(C)(C)OCN1Cc2ccc(N)cc2C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 2/20 0.45
PDK2 Q15119 1/20 0.37
HSD17B3 P37058 1/20 0.35
NAMPT P43490 1/20 0.33
HDAC8 Q9BY41 2/20 0.32
ATAD2 Q6PL18 1/20 0.32
LMNA P02545 2/20 0.32
KDM4E B2RXH2 1/20 0.32
NPC1 O15118 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
S1PR1 P21453 1/20 0.32
TMEM97 Q5BJF2 2/20 0.30
SIGMAR1 Q99720 2/20 0.30
HTR1A P08908 1/20 0.30
ADRA2A P08913 1/20 0.30
ADRA2B P18089 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30885125 0.75 ATAD2 (0.47) NR1H2PDK2HSD17B3NAMPTHDAC8
SCHEMBL30648706 0.75 NR1H2 (0.43) NR1H2PDK2HSD17B3NAMPTHDAC8
SCHEMBL26640019 0.75 NR1H2 (0.43) NR1H2PDK2HSD17B3NAMPTHDAC8
SCHEMBL14067293 0.73 PDK2 (0.43) NR1H2PDK2HSD17B3NAMPTHDAC8
SCHEMBL16370737 0.72 NR1H2 (0.37) NR1H2PDK2HSD17B3NAMPTLMNA
SCHEMBL17797706 0.72 NR1H2 (0.44) NR1H2PDK2HSD17B3NAMPTHDAC8
SCHEMBL17797497 0.71 NR1H2 (0.38) NR1H2PDK2HSD17B3NAMPTHDAC8
SCHEMBL27981478 0.71 HSD17B3 (0.43) NR1H2PDK2HSD17B3NAMPTHDAC8
SCHEMBL17797689 0.71 NR1H2 (0.37) NR1H2PDK2HSD17B3NAMPT
SCHEMBL18491671 0.70 NR1H2 (0.36) NR1H2PDK2HSD17B3NAMPTHDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040063935-A1 Aliphatic nitrogenous five-membered ring compounds TANABE SEIYAKU CO., LTD. (JP) 2004-04-01 US disclosed
EP-1325910-A1 ALIPHATIC NITROGENOUS FIVE-MEMBERED RING COMPOUNDS TANABE SEIYAKU CO., LTD. (JP) 2003-07-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063935-A1 Aliphatic nitrogenous five-membered ring compounds H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, SCN5A, CYP11B1 NR1H2 166/4885PDK2 4546/4885HSD17B3 244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.